Clinical trial · Observational
OLGA Stage is More Appropriate in Predicting Early Gastric Cancer
OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Than Endoscopic Gastric Atrophy Classification and OLGIM Stage: A Prospective Study
NCT02562976CI-TRIAL-00019243completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study was to evaluate characteristics of background mucosa in early gastric cancer (EGC), and to seek for the optimal assessment for EGC screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Gastric Cancer | Early Gastric Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| gastric atrophy and intestinal metaplasia | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- early gastric cancer group
- description
- use Japanese endoscopic gastric atrophy classification, Operative Link on Gastritis Assessment (OLGA), Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) to evaluate the severity of gastric atrophy and intestinal metaplasia in patients with early gastric cancer or high-grade neoplasia(HGN)
- interventionNames
- Other: gastric atrophy and intestinal metaplasia
- label
- non-early gastric cancer group
- description
- patients diagnosed as non- gastritis, gastritis or low-grade neoplasia (LGN) by pathology were defined as non-EGC group
- interventionNames
- Other: gastric atrophy and intestinal metaplasia
Primary outcomes (1)
- measure
- Number of patients with severe gastric atrophy and/or intestinal metaplasia in early gastric cancer and non-early gastric cancer
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * The age of patients is from 40-80 years * Must undergo esophagogastroduodenoscopy Exclusion Criteria: * Clinical diagnosis of advanced gastric cancer * Post-subtotal gastrectomy * Acute upper gastrointestinal bleeding * Severe systemic diseases * Lack histology
References
Publications (0)
Data not yet available
No reference posted for this study.